Botulinum toxin A should not be first-line therapy for overactivebladder

Authors

  • Lesley K. Carr Associate Professor, Department of Surgery, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, ON

DOI:

https://doi.org/10.5489/cuaj.643

Abstract

Downloads

Download data is not yet available.

Author Biography

Lesley K. Carr, Associate Professor, Department of Surgery, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, ON

Downloads

How to Cite

Carr, L. K. (2013). Botulinum toxin A should not be first-line therapy for overactivebladder. Canadian Urological Association Journal, 5(3), 204–9. https://doi.org/10.5489/cuaj.643

Issue

Section

Point-Counterpoint